Postmenopausal hormone therapy and major adverse cardiac events in women with prior myocardial infarction

31 August 2025 (10:45 - 10:55)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Hannah Karin Wood-Kurland

Nordsjaellands Hospital, Hilleroed (Denmark)

4 More presentations in this session

Presentation thumbnail

Participation of women in cardiovascular trials from 2017 to 2023: a systematic review

Professor M. Gulati (Houston, US)

Abstract Slides Video

Presentation thumbnail

Gender differences in the performance of the Chest Pain score and modified HEART score in risk stratification for cardiac events in patients presenting to the Emergency Department with chest pain

Doctor L. Pelagatti (Florence, IT)

Abstract Slides Video

Presentation thumbnail

Cardiovascular risk in autoimmune diseases: associations and interactions with traditional risk factors in a prospective population-based cohort of 450 000 individuals

Mr A. Schuermans (Leuven, BE)

Abstract Slides Video

Presentation thumbnail

Distinct risk patterns of mid-trimester systolic-diastolic blood pressure for individual and co-occurring adverse pregnancy outcomes

Miss F. Yiwen (Tianjin, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Cardiovascular health in women: from hormones to high-risk conditions

The Event

Event poster

ESC Congress 2025

31 August 2025 10:45 CET

You may be interested in

Congress Session

Cardiovascular health in women: from hormones to high-risk conditions

Congress Session

Specific intervention for cardiovascular disease in women

Congress Presentation

Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - discussion

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources